NCT01436539 - Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

July 31, 2013

Conditions

Chronic Hepatitis B

Interventions

DRUG

Adefovir Dipivoxil and polyene phosphatidylcholine

Adefovir Dipivoxil 10 mg once daily for 48 weeks plus Polyene phosphatidylcholine (PPC) 456 mg three times per day for 48 weeks

DRUG

Adefovir Dipivoxil

Adefovir Dipivoxil 10 mg once daily for 48 weeks

Trial Locations (1)

Beijing Ditan Hospital, Capital Medical University, Beijing